ArticleBiomedicines2025

Inferior Outcomes of Fludarabine-Cyclophosphamide-Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia and Anemia.

Tong-Yoon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.